Cargando…

Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam

Multidrug-resistant (MDR) Pseudomonas aeruginosa is one of the main causes of morbidity and mortality in hospitalized patients and the leading cause of nosocomial infections. We investigated, here, two MDR P. aeruginosa clinical isolates from a hospitalized patient with differential antimicrobial re...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Weihua, Hamouche, Joelle El, Wang, Guiqing, Smith, Melissa, Yin, Changhong, Dhand, Abhay, Dimitrova, Nevenka, Fallon, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037351/
https://www.ncbi.nlm.nih.gov/pubmed/32033143
http://dx.doi.org/10.3390/ijms21031026
_version_ 1783500407594549248
author Huang, Weihua
Hamouche, Joelle El
Wang, Guiqing
Smith, Melissa
Yin, Changhong
Dhand, Abhay
Dimitrova, Nevenka
Fallon, John T.
author_facet Huang, Weihua
Hamouche, Joelle El
Wang, Guiqing
Smith, Melissa
Yin, Changhong
Dhand, Abhay
Dimitrova, Nevenka
Fallon, John T.
author_sort Huang, Weihua
collection PubMed
description Multidrug-resistant (MDR) Pseudomonas aeruginosa is one of the main causes of morbidity and mortality in hospitalized patients and the leading cause of nosocomial infections. We investigated, here, two MDR P. aeruginosa clinical isolates from a hospitalized patient with differential antimicrobial resistance to ceftazidime/avibactam (CZA), ceftolozane/tazobactam (C/T), and piperacillin/tazobactam (P/T). Their assembled complete genomes revealed they belonged to ST235, a widespread MDR clone; and were isogenic with only a single nucleotide variant, causing G183D mutation in AmpC β-lactamase, responsible for a phenotypic change from susceptible to resistant to CZA and C/T. Further epigenomic profiling uncovered two conserved DNA methylation motifs targeted by two distinct putative methyltransferase-containing restriction-modification systems, respectively; more intriguingly, there was a significant difference between the paired isolates in the pattern of genomic DNA methylation and modifications. Moreover, genome-wide gene expression profiling demonstrated the inheritable genomic methylation and modification induced 14 genes being differentially regulated, of which only toxR (downregulated), a regulatory transcription factor, had its promoter region differentially methylate and modified. Since highly expressed opdQ encodes an OprD porin family protein, therefore, we proposed an epigenetic regulation of opdQ expression pertinent to the phenotypic change of P. aeruginosa from resistant to susceptible to P/T. The disclosed epigenetic mechanism controlling phenotypic antimicrobial resistance deserves further experimental investigation.
format Online
Article
Text
id pubmed-7037351
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70373512020-03-11 Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam Huang, Weihua Hamouche, Joelle El Wang, Guiqing Smith, Melissa Yin, Changhong Dhand, Abhay Dimitrova, Nevenka Fallon, John T. Int J Mol Sci Article Multidrug-resistant (MDR) Pseudomonas aeruginosa is one of the main causes of morbidity and mortality in hospitalized patients and the leading cause of nosocomial infections. We investigated, here, two MDR P. aeruginosa clinical isolates from a hospitalized patient with differential antimicrobial resistance to ceftazidime/avibactam (CZA), ceftolozane/tazobactam (C/T), and piperacillin/tazobactam (P/T). Their assembled complete genomes revealed they belonged to ST235, a widespread MDR clone; and were isogenic with only a single nucleotide variant, causing G183D mutation in AmpC β-lactamase, responsible for a phenotypic change from susceptible to resistant to CZA and C/T. Further epigenomic profiling uncovered two conserved DNA methylation motifs targeted by two distinct putative methyltransferase-containing restriction-modification systems, respectively; more intriguingly, there was a significant difference between the paired isolates in the pattern of genomic DNA methylation and modifications. Moreover, genome-wide gene expression profiling demonstrated the inheritable genomic methylation and modification induced 14 genes being differentially regulated, of which only toxR (downregulated), a regulatory transcription factor, had its promoter region differentially methylate and modified. Since highly expressed opdQ encodes an OprD porin family protein, therefore, we proposed an epigenetic regulation of opdQ expression pertinent to the phenotypic change of P. aeruginosa from resistant to susceptible to P/T. The disclosed epigenetic mechanism controlling phenotypic antimicrobial resistance deserves further experimental investigation. MDPI 2020-02-04 /pmc/articles/PMC7037351/ /pubmed/32033143 http://dx.doi.org/10.3390/ijms21031026 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Weihua
Hamouche, Joelle El
Wang, Guiqing
Smith, Melissa
Yin, Changhong
Dhand, Abhay
Dimitrova, Nevenka
Fallon, John T.
Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title_full Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title_fullStr Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title_full_unstemmed Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title_short Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
title_sort integrated genome-wide analysis of an isogenic pair of pseudomonas aeruginosa clinical isolates with differential antimicrobial resistance to ceftolozane/tazobactam, ceftazidime/avibactam, and piperacillin/tazobactam
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037351/
https://www.ncbi.nlm.nih.gov/pubmed/32033143
http://dx.doi.org/10.3390/ijms21031026
work_keys_str_mv AT huangweihua integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT hamouchejoelleel integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT wangguiqing integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT smithmelissa integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT yinchanghong integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT dhandabhay integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT dimitrovanevenka integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam
AT fallonjohnt integratedgenomewideanalysisofanisogenicpairofpseudomonasaeruginosaclinicalisolateswithdifferentialantimicrobialresistancetoceftolozanetazobactamceftazidimeavibactamandpiperacillintazobactam